“…In intact animals and in vitro studies, atypical fl-ARs respond to novel lipolytic fi-AR agonists such as BRL37344 and ICID7114, are resistant to blockade by conventional fl-AR antagonists such as (-)-propranolol, and often display resistance to desensitization upon prolonged exposure to agonists (Arch & Kaumann,1993). Receptors with these functional characteristics have been described in brown and white adipose tissue (Harms et al, 1977;Arch et al, 1984, Hollenga & Zaagsma, 1989; skeletal muscle (Abe et al, 1993;Liu & Stock, 1995), and multiple regions from the gastrointestinal tract (Coleman et al, 1987;Bond & Clarke, 1988;Croci et al,1988;Blue et al, 1990;McLaughlin & MacDonald, 1990;Bianchetti & Manara, 1990;McLaughlin & MacDonald, 1991;Canfield & Paraskeva, 1992 ;Canfield & Abdul-Ghaffar, 1992;Roberts et al, 1995;Cohen et al, 1995).…”